产品名称
Anti-NQO1 Rabbit pAb, liquid, Calbiochem®
biological source
rabbit
antibody form
purified antibody
antibody product type
primary antibodies
clone
polyclonal
form
liquid
species reactivity
human, mouse
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
avoid repeated freeze/thaw cycles
dilution
(Immunoblotting (1-5 µg/mL))
isotype
IgG
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
Quality Level
Gene Information
human ... NQO1(1728)
Analysis Note
Negative Control
293T cells
293T cells
Positive Control
Human stomach tissue, Mouse brain tissue, HepG2 cells
Human stomach tissue, Mouse brain tissue, HepG2 cells
Application



Immunoblotting (1-5 g/ml)
Disclaimer
Toxicity: Regulatory Review (Z)
General description
Purified rabbit polyclonal antibody. Recognizes the ~30 kDa NQO1 protein.
Recognizes the ~30 kDa NQO1 protein in human stomach tissue, mouse brain tissue, and HepG2 cells.
This Anti-NQO1 Rabbit pAb is validated for use in Immunoblotting for the detection of NQO1.
Immunogen
Full-length, recombinant human NQO1 (aa 1-274)
Human
Other Notes
Variables associated with assay conditions will dictate the proper working dilution.
Physical form
In PBS, pH 7.2.
Preparation Note
Following initial thaw, aliquot and freeze (-20°C).
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品?
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Teresa Riccioni et al.
Frontiers in psychiatry, 1, 22-22 (2010-01-01)
Adenosine A(2A) receptors seem to exist in typical (more in striatum) and atypical (more in hippocampus and cortex) subtypes. In the present study, we investigated the affinity of two adenosine A(2A) receptor antagonists, ST1535 [2 butyl -9-methyl-8-(2H-1,2,3-triazol 2-yl)-9H-purin-6-xylamine] and KW6002
Alessandro Tozzi et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 31(5), 1850-1862 (2011-02-04)
A(2A) adenosine receptor antagonists are currently under investigation as potential therapeutic agents for Parkinson's disease (PD). However, the molecular mechanisms underlying this therapeutic effect is still unclear. A functional antagonism exists between A(2A) adenosine and D(2) dopamine (DA) receptors that
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持